Jeffrey W. Albers

Insider Reports History

Entity
Individual
Location
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, MA
Signature
/s/ Melissa Masse, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey W. Albers:

Insider Reports Filed by Jeffrey W. Albers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Jan 21, 2025 5 -$1.3M 4 Jan 23, 2025 Director
BPMC Blueprint Medicines Corp Jan 13, 2025 3 -$331K 4 Jan 15, 2025 Director
BPMC Blueprint Medicines Corp Dec 19, 2024 6 -$1.35M 4 Dec 20, 2024 Director
BPMC Blueprint Medicines Corp Nov 7, 2024 3 -$330K 4 Nov 12, 2024 Director
SYRE Spyre Therapeutics, Inc. Nov 6, 2024 1 -$246K 4 Nov 8, 2024 Director
SYRE Spyre Therapeutics, Inc. Oct 25, 2024 1 -$10.9K 4 Oct 28, 2024 Director
BPMC Blueprint Medicines Corp Sep 9, 2024 4 -$1.33M 4 Sep 11, 2024 Director
KYMR Kymera Therapeutics, Inc. Aug 26, 2024 3 -$194K 4 Aug 26, 2024 Director
KYMR Kymera Therapeutics, Inc. Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
SYRE Spyre Therapeutics, Inc. May 14, 2024 1 $0 4 May 16, 2024 Director
BPMC Blueprint Medicines Corp Mar 20, 2024 9 -$2.01M 4 Mar 22, 2024 Director
BPMC Blueprint Medicines Corp Mar 7, 2024 1 -$1M 4 Mar 26, 2024 Director
KYMR Kymera Therapeutics, Inc. Feb 20, 2024 6 -$144K 4 Feb 21, 2024 Director
BPMC Blueprint Medicines Corp Jan 25, 2024 8 -$1.87M 4 Jan 29, 2024 Director
KYMR Kymera Therapeutics, Inc. Jan 23, 2024 3 -$197K 4 Jan 23, 2024 Director
BPMC Blueprint Medicines Corp Dec 11, 2023 3 -$215K 4 Dec 13, 2023 Director
BPMC Blueprint Medicines Corp Nov 30, 2023 3 -$173K 4 Dec 4, 2023 Director
BPMC Blueprint Medicines Corp Nov 24, 2023 4 -$985K 4 Nov 28, 2023 Director
SYRE Spyre Therapeutics, Inc. Nov 22, 2023 3 $0 4/A Dec 8, 2023 Director
SYRE Spyre Therapeutics, Inc. Nov 22, 2023 0 $0 3/A Dec 8, 2023 Director
BPMC Blueprint Medicines Corp Nov 1, 2023 10 -$241K 4 Nov 3, 2023 Director
BPMC Blueprint Medicines Corp Sep 27, 2023 8 -$1.2M 4 Sep 29, 2023 Director
BPMC Blueprint Medicines Corp Aug 24, 2023 6 -$1.2M 4 Aug 28, 2023 Director
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
KYMR Kymera Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
BPMC Blueprint Medicines Corp Mar 6, 2023 2 -$447K 4 Mar 8, 2023 Director
BPMC Blueprint Medicines Corp Dec 5, 2022 5 -$833K 4 Dec 7, 2022 Director
BPMC Blueprint Medicines Corp Aug 19, 2022 7 -$554K 4 Aug 23, 2022 Director
BPMC Blueprint Medicines Corp Aug 16, 2022 7 -$1.2M 4 Aug 18, 2022 Director
BPMC Blueprint Medicines Corp Aug 8, 2022 5 -$632K 4 Aug 10, 2022 Director
MGTA Magenta Therapeutics, Inc. Jun 28, 2022 1 $0 4 Jun 30, 2022 Director
KYMR Kymera Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
BPMC Blueprint Medicines Corp May 16, 2022 7 -$949K 4 May 18, 2022 Director
BPMC Blueprint Medicines Corp Apr 6, 2022 3 -$276K 4 Apr 8, 2022 CEO AND PRESIDENT, Director
BPMC Blueprint Medicines Corp Mar 3, 2022 10 -$1.69M 4 Mar 8, 2022 CEO AND PRESIDENT, Director
BPMC Blueprint Medicines Corp Mar 1, 2022 2 $0 4 Mar 3, 2022 CEO AND PRESIDENT, Director
BPMC Blueprint Medicines Corp Nov 15, 2021 8 -$3.08M 4 Nov 17, 2021 CEO and President, Director
BPMC Blueprint Medicines Corp Nov 1, 2021 3 -$501K 4 Nov 3, 2021 CEO and President, Director
BPMC Blueprint Medicines Corp Aug 26, 2021 2 $29.9K 4 Aug 30, 2021 CEO and President, Director
BPMC Blueprint Medicines Corp Aug 19, 2021 6 -$2.04M 4 Aug 23, 2021 CEO and President, Director
KYMR Kymera Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
MGTA Magenta Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director
BPMC Blueprint Medicines Corp May 12, 2021 7 -$2.04M 4 May 14, 2021 CEO and President, Director